Bilateral intravitreal dexamethasone implant for retinitis pigmentosa-related macular edema

Creative Commons License

SAATCİ A. O., Selver O. B., Seymenoglu G., YAMAN A.

Case Reports in Ophthalmology, vol.4, no.1, pp.53-58, 2013 (Scopus) identifier identifier

  • Publication Type: Article / Article
  • Volume: 4 Issue: 1
  • Publication Date: 2013
  • Doi Number: 10.1159/000350544
  • Journal Name: Case Reports in Ophthalmology
  • Journal Indexes: Scopus
  • Page Numbers: pp.53-58
  • Keywords: Intravitreal dexamethasone implant, Macular edema, Retinitis pigmentosa
  • Dokuz Eylül University Affiliated: Yes


Purpose: To report the efficacy of intravitreal dexamethasone implant in a patient with retinitis pigmentosa and bilateral cystoid macular edema unresponsive to topical carbonic anhydrase inhibitors. Case Report: A 36-year-old man with bilateral cystoid macular edema associated with retinitis pigmentosa that was unresponsive to topical carbonic anhydrase inhibitors underwent bilateral 0.7-mg intravitreal dexamethasone implants two weeks apart. Spectral domain optical coherence tomography revealed resolution of macular edema one week following each injection in both eyes and his visual acuity improved. However, macular edema recurred two months later in OS and three months later in OD. Second implant was considered for both eyes. No implant-related complication was experienced during the follow-up of seven months. Conclusion: Inflammatory process seems to play a role in retinitis pigmentosa. Intravitreal dexamethasone implant may offer retina specialists a therapeutic option especially in cases unresponsive to other treatment regimens in eyes with retinitis pigmentosa-related macular edema. © 2013 S. Karger AG, Basel.